Supposing that ITPR1 is truly protective of RCC cells, its downregulation in ccRCC organoids after cabozantinib treatment could be indicative of reliance on separate pathways for survival or suggestive that it is not critical for tumor survival. Here, ITPR1 is linked to nonpapillary renal cell carcinoma.